Clinical trial
Ozurdex Endophtamitis Cohort, Prognostic Assessment at 12 Months
NCT06268561 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Saint Etienne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ozurdex Endophtamitis Cohort, Prognostic Assessment at 12 Months
- Lead sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 5, 2023
- Completion date
- June 30, 2024
- Enrollment
- 8 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.